EHA 2019: New treatment for sickle cell disease

Jo Howard | EHA 2019 | Juni 17, 2019

Föreläsare: Jo Howard

Sickle cell disease is a genetic blood disorder that affects millions worldwide and can cause recurrent pain episodes and chronic anemia, leading to damaged organs, stroke and premature death.In this MEDtalkJo Howard present data that show that voxelotor, a new treatment for sickle cell disease significantly improves anemia and hemolysis, andprovides strong evidence that voxelotorhas the potential to be a disease-modifying treatment that could prevent chronic organ damage.